Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Hims, Novo Nordisk and Shares

Digest more
Top News
Overview
 · 1d
Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs
Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo's branded medicines through its platform.

Continue reading

 · 1d · on MSN
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit
 · 1d · on MSN
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
 · 1d
Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform
Hims & Hers' (HIMS.N) shares were up over 50% in premarket trading on Monday following reports Novo Nordisk (NOVOb.CO) plans to sell ​its weight-loss drugs on the telehealth firm's platform, signaling...

Continue reading

 · 1d
Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform
 · 1d
Novo Nordisk Hims And Hers Deal Reframes Obesity Drug Growth Story
1don MSN

Hims & Hers Made a Surprising Concession to End Its GLP‑1 Beef With Novo Nordisk

Both companies’ stocks rose in the wake of the news.
  • Privacy
  • Terms